|
|
|
|
Дата |
|---|
| 15.03.2026 |
| 12.03.2026 |
| 11.03.2026 |
| 10.03.2026 |
| 09.03.2026 |
| 08.03.2026 |
| 05.03.2026 |
| 04.03.2026 |
| 03.03.2026 |
| 02.03.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
80.79
|
79.21
|
80.79
|
79.53
|
|
|
3 980 932.23
|
311.00
|
|
|
|
81.53
|
79.00
|
81.90
|
80.79
|
|
|
14 418 303.56
|
572.00
|
|
|
|
80.27
|
79.85
|
81.53
|
81.53
|
|
|
27 733 031.45
|
423.00
|
|
|
|
80.74
|
80.21
|
82.00
|
80.27
|
|
|
13 688 899.12
|
502.00
|
|
|
|
81.50
|
80.62
|
83.00
|
80.74
|
|
|
32 195 276.26
|
622.00
|
|
|
|
79.17
|
79.20
|
82.55
|
81.50
|
|
|
16 016 807.52
|
578.00
|
|
|
|
79.82
|
79.00
|
80.50
|
79.17
|
|
|
23 169 382.80
|
500.00
|
|
|
|
78.11
|
78.20
|
80.00
|
79.82
|
|
|
11 167 393.65
|
488.00
|
|
|
|
78.20
|
77.00
|
79.50
|
78.11
|
|
|
17 442 504.75
|
716.00
|
|
|
|
78.00
|
77.00
|
78.87
|
78.20
|
|
|
15 702 114.41
|
521.00
|
Период |
|---|
| 2022, регулярные |
| 2020, регулярные |
| 2018, регулярные |
| 2017, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2012, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
13.04.2023
|
18.04.2023 |
2 EGP |
|
21.04.2021
|
25.04.2021 |
2.95 EGP |
|
02.05.2019
|
05.05.2019 |
4 EGP |
|
06.04.2018
|
10.04.2018 |
4.5 EGP |
|
08.05.2017
|
09.05.2017 |
3.5 EGP |
|
21.04.2016
|
24.04.2016 |
3.5 EGP |
|
23.04.2013
|
24.04.2013 |
3 EGP |
|
24.05.2012
|
27.05.2012 |
3 EGP |
|
29.04.2011
|
02.05.2011 |
2.5 EGP |
Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) is an Egypt-based public shareholding company that operates in the pharmaceuticals industry. The Company is a manufacturer and exporter of pharmaceuticals, and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones. The Company produces dosage forms, such as spansule capsules (long-acting), as well as non-traditional dosage forms, such as the soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets
